Influenza is a major cause of respiratory illness in adults and children worldwide. Both influenza A and B viruses have a segmented genome consisting of eight negative-stranded RNA segments, six of which code for the internal proteins nucleoprotein (NP), matrix protein (M), nonstructural protein (NS), and RNA polymerase proteins (PA, PB1, PB2), and two of which code for the surface glycoproteins hemagglutinin (HA) and neuraminidase (NA). Viral infection is initiated by HA binding to the sialic acid-containing host cell receptor, while NA cleaves the sialic acid to promote the release of virus from infected cells. Functional coordination of these two proteins is required for efficient virus replication (14) . However, the natural balance of virus infection and release can be disturbed by events such as reassortment.
The influenza HA surface antigen is synthesized as a single polypeptide that is subsequently cleaved into two chains, HA1 and HA2. Antigenic variation of the HA protein of influenza viruses occurs predominantly in the HA1 domain (15) . The HA gene of influenza B viruses can also undergo antigenic drift, although this phenomenon occurs at a lower rate compared to that of influenza A viruses (18) . In addition, influenza B viruses use other mechanisms, such as insertion/deletion and reassortment with antigenically and genetically distinct cocirculating viruses, to generate genetic diversity (8, 10, 12, 17, 18) . Recent isolates of influenza B viruses consist of two major phylogenetic lineages: B/Victoria/2/87 and B/Yamagata/16/88. Circulation of the B/Yamagata/16/88 viruses was highly restricted in Asia during the 1990s but emerged during 2001 in various parts of the world (4). One of the strains, B/Hong Kong/1351/02, was determined to be a reassortant with the HA and NA genes arising from two distinct lineages (13) . In this report, we studied the genetic diversity of influenza B viruses by molecular analysis of 105 influenza B-positive respiratory specimens collected from southeast Asia in 2002.
MATERIALS AND METHODS
Clinical specimens and RNA extraction. Nasal specimens were collected from 6-to 36-month-old subjects with respiratory illness who enrolled in an experimental pediatric influenza vaccine trial conducted in the Philippines and Thailand during the year of 2002 (from March to November). Viral RNA was extracted from influenza B-positive specimens by an automated method as described previously (3) . Briefly, viral RNA was extracted from 125 l of clinical specimen or tissue culture supernatant with addition of 125 l of 2ϫ lysis buffer (Applied Biosystems, Foster City, CA) and 50 g of carriers (Sigma, St. Louis, MO). A total of 250 l of cell lysate was processed using the ABI Prism 6700 workstation (Applied Biosystems, Foster City, CA), and the RNA was eluted in a total volume of 150 l of elution buffer (Applied Biosystems, Foster City, CA).
Amplification and sequencing of the HA1 gene. HA1 cDNA fragments corresponding to nucleotides 98 to 836 were amplified by reverse transcription-PCR (RT-PCR) with oligos 5Ј-ATAACATCGTCAAACTCACC-3Ј and 5Ј-GCACC ATGTAATCAACAACA-3Ј and sequenced as described previously (4) . Multiple sequence alignment was performed to determine the phylogenetic relationship between the clinical virus isolates and the reference strains (B/Victoria/504/ 00, B/Hong Kong/330/01, and B/Hong Kong/1351/02) using MegAlign5.03 software (DNASTAR Inc., Madison, WI) and the ClustalV method.
Real-time PCR assay of NA gene. A high-throughput TaqMan RT-PCR assay was designed to target the NA gene of influenza B virus. Each primer-probe set (Table 1 ) was chosen based on the different nucleotide composition of the NA gene in the B/Hong Kong/330/01 and B/Hong Kong/1351/02 viruses. Both sets of primer-probe were designed using Primer Express Software (Applied Biosystems, Foster City, CA). The primers were obtained from Invitrogen Life Technology (Carlsbad, CA), and the probes which contained the 5Ј reporter dye 6-carboxyfluorescein (FAM) and the 3Ј minor groove binder (MGB) were synthesized by Applied Biosystems (Foster City, CA). The TaqMan RT-PCR procedure was described previously (6) , and the real-time RT-PCRs were carried out in an ABI Prism 7900 sequence detection system (Applied Biosystems, Foster City, CA). The reverse transcription reactions were performed at 48°C for 30 min, followed by 10 min at 95°C to activate AmpliTaq DNA polymerase and then by 40 cycles of amplification, including 15 s at 95°C and 1 min at 60°C.
Amplification and sequence of NA, NP, NS, M, PA, PB1, and PB2 gene fragments. All gene fragments were amplified by RT-PCR and sequenced using an ABI 3100 Genetic Analyzer. Table 2 shows the oligo primers used for PCR and sequencing. A multiple sequence alignment was performed to determine the phylogenetic relationship (as described above).
RESULTS

Characterization of influenza B viruses by sequencing HA1 gene fragments.
Based on HA1 sequences, we found that 96.2% of the specimens belonged to the B/Victoria/2/87 lineage, which were further subgrouped into B/Hong Kong/330/ 01-like (27.7%) and B/Hong Kong/1351/02-like (72.3%) viruses. Of the 105 viruses examined, only a small percentage of the viruses (3.8%) was found to belong to the B/Yamagata/ 16/88 lineage ( Table 3 , group 1). Among these, significant antigenic drift was present in the deduced amino acid sequences of the HA1 protein compared to those of the reference strain B/Victoria/504/00. A total of 17 amino acid substitutions were identified, and 6 of them occurred at positions 29, 88, 162, 179, 183, and 184, respectively. These substitutions were identical to those found in the HA1 protein of B/Hong Kong/330/01. In contrast, the HA1 drift in the B/Hong Kong/ 330/01-like viruses and B/Hong Kong1351/02-like viruses was minimal (Table 3 , group 2) or sporadic ( Table 3 , group 3), respectively. However, all the isolates contained the same amino acid substitution at position 197.
The time distribution of our specimens is shown in Fig. 1 . It is interesting to note that the specimens containing the B/Hong Kong/330/01-like viruses were clustered at the end of the collection period during October and November of 2002. Since B/Hong Kong/330/01 was circulating in previous influenza seasons, we further investigated whether there was any change in its genetic compositions. (Table 4) . (Table 3) . Among these, the deduced amino acid sequence of SA10 (group 1 virus, Table 3 ) is very similar to that of isolate B/jhb/77/01 from South Africa (1), except at positions 88, 172, and 197, and it is nearly identical to that of WV5, an isolate from Europe in the 2001-2002 season (4), except at position 172. Within the B/Victoria/2/87 group, we found a substitution of amino acid 197 in all the HA1 amino acid sequences of B/Hong Kong-like viruses. Previously, we reported this change (4) and showed that a new N-glycosylation site (NET) was created as a result of the substitution. Nakagawa et al. also found a new glycosylation site in the HA of influenza B isolates in Japan during 2002-2003 (11) and demonstrated that the amino acid sequence 197 to 199 determined reactivity to certain monoclonal antibodies. In our study, all but one B/Hong Kong-like HA1 sequence exhibited NET at amino acids 197 to 199. 
Genetic reassortment has recently been a major feature in the evolution of both influenza A and B viruses (7) . Cocirculation of multiple subtypes and lineages of influenza viruses can allow genetic reassortment to occur during mixed infections. Shaw 
